A cheap drug called Minocycline, which is normally prescribed for pneumonia and acne will be tested in a new trial to reduce the symptoms of psychosis in patients suffering from schizophrenia.

Schizophrenia is a mental disorder characterized by a breakdown of thought processes and by poor emotional responsiveness. According to the WHO the disorder affects around 0.3–0.7% of people at some point in their life, or 24 million people worldwide as of 2011. There is no general cure and the pharmacologic treatment of schizophrenia leaves much to be desired.

Now the National Institute for Health Research in the U.K. is funding a large research trial on More >